P1.18-05 ChemoXRT W/ Consolidation Pembrolizumab in Unresectable Stage III NSCLC: Long-Term Survival Update and Analysis of Post-Progression Therapy

Autor:	Robin Zon, Ebenezer A. Kio, Karen L. Reckamp, Goetz H. Kloecker, Nasser H. Hanna, Sandra K. Althouse, M. Williamson, C. Yeon, B. Adesunloye, Salma K. Jabbour, G. Durm, Ryan D. Gentzler, Shadia I. Jalal, Wael A. Harb, Marianna Koczywas, Radhika Walling, Robert M. Langdon, Ahad Ali Sadiq
Rok vydání:	2019
Předmět:	Pulmonary and Respiratory Medicine Oncology medicine.medical_specialty Consolidation (soil) business.industry Internal medicine Long term survival medicine Stage III NSCLC Pembrolizumab business
Zdroj:	Journal of Thoracic Oncology. 14:S627
ISSN:	1556-0864
DOI:	10.1016/j.jtho.2019.08.1321
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7fd8160ed3e24c1ada44a1fa7aba85cb https://doi.org/10.1016/j.jtho.2019.08.1321 Zobrazit plný text záznamu